Skip to content

SINGLE-CENTRE/OPEN/RANDOMIZED/PLACEBO-CONTROLLED, 16 WEEKS, PHASE I CLINICAL TRIAL OF ANCILLA DOMINI OB NANO-INVERSE TRANSCRIPTION THERAPEUTICS ON OBESITY DECIMATION/NORMALIZATION

Single-Centre/Open/Randomized/Placebo-Controlled, 16 Weeks, Phase I Clinical Trial Of Ancilla Domini Chot-OB Agonist On Obesity Decimation/Normalization

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
PACTR
Registry ID
PACTR202410686559500
Enrollment
30
Registered
2024-10-03
Start date
2024-11-12
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine

Interventions

Ancilla Domini CHoTA OB
Placebo

Sponsors

Ancilla Domini International Researchers
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Adults 18+ years old 2. Male/Female 3. Residents in any part of Ghana 4. All nationalities/race 5. People with OBESITY of any grade

Exclusion criteria

Exclusion criteria: 1. Children/ under 18 years 2. Pregnant/ Lactating Mothers 3. Diabetes Mellitus (I)/ Insulin dependent Diabetes.

Design outcomes

Primary

MeasureTime frame
1. Over 80% research treatment participants would loose over 10% of their body weight;All research participants treatment group would experience little/no side effects with the intervention - (99.9:0.1)% Safety/Risk Ratio

Secondary

MeasureTime frame
Participants in intervention group would experience reversion/cessation of further complications of Obesity;Over 80% of participants shall achieve their healthy Body Mass Index;Research subjects in the intervention group would be able to decide by themselves how much weight they desire to shed in apropos to their health/other underlying factor

Countries

Ghana

Contacts

Public ContactAlee Geoffrey

Public Relations Executive of Ancilla Domini International Researchers

denudation2015@gmail.com+2347041388422

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026